Search results
We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.
- Careers
Find your place at Lilly with Lilly Careers. For more than a...
- Investor Relations
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for...
- Login
Connecting to Lilly. The following services are available to...
- Trials
Lilly is committed to the discovery, research and...
- Annual Reports
Search Lilly.com For Content... Annual Reports Annual...
- Individual Investors
EQ Shareowner Services administers the Shareowner Service...
- Quarterly Results
Search Lilly.com For Content... Quarterly Results Quarterly...
- Webcasts & Presentations
Speaker: Patrik Jonsson, Executive Vice President, President...
- Careers
Lilly unites caring with discovery to create medicines that make life better for people around the world.
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
4 days ago · The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
People also ask
What is Lilly's new approach to clinical trials?
Where is Eli Lilly based?
When did Lilly become a company?
Who was Eli Lilly and what did he do?
4 days ago · Lilly intends to donate Kisunla to the Lilly Cares Foundation, a separate nonprofit organization that makes medicines available at no cost to qualified Americans, including some Medicare beneficiaries, who meet financial eligibility and other criteria. This is consistent with Lilly's long history of supporting access to our products to patients with financial need through medication donations to charitable organizations.
3 days ago · The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s. (Eli Lilly and Company via AP) WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early ...